Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis

British Journal of Cancer

Volumn 111, Issue 3, 2014, Pages 559-567

  Schmaus, A ^a,b   Klusmeier, S ^a,b   Rothley, M ^a,b   Dimmler, A ^c   Sipos, B ^d   Faller, G ^c   Thiele, W ^a,b   Allgayer, H ^a   Hohenberger, P ^a   Post, S ^a   Sleeman, J P ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c Institut und Gemeinschaftspraxis Fü R Pathologie An Den St Vincentiuskliniken Karlsruhe   (Germany)

^d Universitä Tsklinikum Tü Bingen Department of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISACCHARIDE; HYALURONAN OLIGOSACCHARIDE; HYALURONIC ACID; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GEL PERMEATION CHROMATOGRAPHY; HUMAN; INTERSTITIAL FLUID; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; TUMOR GROWTH; TUMOR INTERSTITIAL FLUID; ULTRACENTRIFUGATION;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EXTRACELLULAR FLUID; HUMANS; HYALURONIC ACID; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS; TUMOR MARKERS, BIOLOGICAL;

EID: 84905283210     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.332     Document Type: Article

References (80)

1. Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, Kumar P, Mitsios N, Slevin M (2006) Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain J Neurol 129: 2158-2176.
2. Anttila MA, Tammi RH, Tammi MI, Syrjänen KJ, Saarikoski SV, Kosma VM (2000) High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 60: 150-155.
3. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156: 529-536.
4. Benitez A, Yates TJ, Lopez LE, Cerwinka WH, Bakkar A, Lokeshwar VB (2011) Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Res 71: 4085-4095.
5. Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, Simpson MA (2009) Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol 174: 1027-1036.
6. Bourguignon LYW, Wong G, Earle CA, Xia W (2011) Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFkB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) 68: 671-693.
7. Campo GM, Avenoso A, D'Ascola A, Scuruchi M, Prestipino V, Nastasi G, Calatroni A, Campo S (2012) The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis. J Cell Biochem 113: 1852-1867.
8. Chajara A, Raoudi M, Delpech B, Leroy M, Basuyau JP, Levesque H (2000) Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol 20: 1480-1487.
9. Dang S, Peng Y, Ye L, Wang Y, Qian Z, Chen Y, Wang X, Lin Y, Zhang X, Sun X, Wu Q, Cheng Y, Nie H, Jin M, Xu H (2013) Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7. Clin Dev Immunol 2013: 712561.
10. David-Raoudi M, Tranchepain F, Deschrevel B, Vincent J-C, Bogdanowicz P, Boumediene K, Pujol J-P (2008) Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc 16: 274-287.
11. Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, Soloway MS, Lokeshwar VB (2004) Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Int J Cancer 112: 121-129.
12. Enegd B, King JAJ, Stylli S, Paradiso L, Kaye AH, Novak U (2002) Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 50: 1311-1318.
13. Fieber C, Baumann P, Vallon R, Termeer C, Simon JC, Hofmann M, Angel P, Herrlich P, Sleeman JP (2004) Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 117: 359-367.
14. Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB (2003) Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 106: 438-445.
15. Frost GI, Csóka AB, Wong T, Stern R, Csóka TB (1997) Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 236: 10-15.
16. Fuchs K, Hippe A, Schmaus A, Homey B, Sleeman JP, Orian-Rousseau V (2013) Opposing effects of high-and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Dis 4: e819.
17. Gao F, Liu Y, He Y, Yang C, Wang Y, Shi X, Wei G (2010) Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 29: 107-116.
18. Gao F, Yang CX, Mo W, Liu YW, He YQ (2008) Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Investig Med 31: E106-E116.
19. Gomez CS, Gomez P, Knapp J, Jorda M, Soloway MS, Lokeshwar VB (2009) Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. J Urol 182: 1350-1356.
20. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
21. Harada H, Takahashi M (2007) CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. J Biol Chem 282: 5597-5607.
22. Itano N, Sawai T, Atsumi F, Miyaishi O, Taniguchi S, Kannagi R, Hamaguchi M, Kimata K (2004) Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem 279: 18679-18687.
23. Itano N, Sawai T, Miyaishi O, Kimata K (1999b) Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 59: 2499-2504.
24. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K (1999a) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085-25092.
25. Jackson DG (2009) Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev 230: 216-231.
26. Jacobson A, Rahmanian M, Rubin K, Heldin P (2002) Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer 102: 212-219.
27. Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91: 221-264.
28. Kosaki R, Watanabe K, Yamaguchi Y (1999) Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res 59: 1141-1145.
29. Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA (2006) Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 169: 1415-1426.
30. Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, Amano J, Kawakubo M, Kannagi R, Kimata K, Taniguchi S, Itano N (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170: 1086-1099.
31. Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, Sano K, Fujimori M, Amano J, Ohhashi T, Kannagi R, Kimata K, Taniguchi S, Itano N (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 172: 179-193.
32. Kramer MW, Golshani R, Merseburger AS, Knapp J, Garcia A, Hennenlotter J, Duncan RC, Soloway MS, Jorda M, Kuczyk MA, Stenzl A, Lokeshwar VB (2010) HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer. Eur Urol 57: 86-93.
33. Krishnan J, Kirkin V, Steffen A, Hegen M, Weih D, Tomarev S, Wilting J, Sleeman JP (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63: 713-722.
34. Kumar S, West DC, Ponting JM, Gattamaneni HR (1989) Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer 44: 445-448.
35. Laurent TC, Fraser JR (1992) Hyaluronan. FASEB J Off Publ Fed Am Soc Exp Biol 6: 2397-2404.
36. Leong SPL, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Werner JA, Kitagawa Y (2007) Patterns of metastasis in human solid cancers. Cancer Treat Res 135: 209-221.
37. Lesley J, Hascall VC, Tammi M, Hyman R (2000) Hyaluronan binding by cell surface CD44. J Biol Chem 275: 26967-26975.
38. Lin M, Ma S-P, Lin HZ, Ji P, Xie D, Yu J-X (2010) Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin Exp Metastasis 27: 123-132.
39. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL (1996) Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 56: 651-657.
40. Lokeshwar VB, Obek C, Soloway MS, Block NL (1997) Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 57: 773-777.
41. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276: 11922-11932.
42. Lokeshwar VB, Selzer MG (2000) Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 275: 27641-27649.
43. Matou-Nasri S, Gaffney J, Kumar S, Slevin M (2009) Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin. Int J Oncol 35: 761-773.
44. Minsky BD, Mies C, Rich TA, Recht A (1989) Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 17: 311-318.
45. Monzon ME, Fregien N, Schmid N, Falcon NS, Campos M, Casalino-Matsuda SM, Forteza RM (2010) Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. J Biol Chem 285: 26126-26134.
46. Nestl A, Von Stein OD, Zatloukal K, Thies WG, Herrlich P, Hofmann M, Sleeman JP (2001) Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 61: 1569-1577.
47. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA (2005) Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 98: 193-202.
48. Patel S, Turner PR, Stubberfield C, Barry E, Rohlff CR, Stamps A, McKenzie E, Young K, Tyson K, Terrett J, Box G, Eccles S, Page MJ (2002) Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer. Int J Cancer 97: 416-424.
49. Pham HT, Block NL, Lokeshwar VB (1997) Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Cancer Res 57: 778-783.
50. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ, Johansson R, Bohm J, Hollmen S, Kosma VM (2001) Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 95: 12-17.
51. Poola I, Abraham J, Marshalleck JJ, Yue Q, Lokeshwar VB, Bonney G, Dewitty RL (2008) Molecular risk assessment for breast cancer development in patients with ductal hyperplasias. Clin Cancer Res 14: 1274-1280.
52. Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, Lokeshwar VB (2003) Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. Cancer Res 63: 2638-2644.
53. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E, Kosma VM (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342-347.
54. Saito T, Kawana H, Azuma K, Toyoda A, Fujita H, Kitagawa M, Harigaya K (2011) Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane. Int J Oncol 39: 1311-1320.
55. Savani RC, Hou G, Liu P, Wang C, Simons E, Grimm PC, Stern R, Greenberg AH, DeLisser HM, Khalil N (2000) A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol 23: 475-484.
56. Setala LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Agren UM, Parkkinen J, Alhava EM, Kosma VM (1999) Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 79: 1133-1138.
57. Simpson MA (2006) Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol 169: 247-257.
58. Simpson MA, Lokeshwar VB (2008) Hyaluronan and hyaluronidase in genitourinary tumors. Front Biosci 13: 5664-5680.
59. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma V-M (2011) Hyaluronan in human malignancies. Exp Cell Res 317: 383-391.
60. Sleeman J, Schmid A, Thiele W (2009) Tumor lymphatics. Semin Cancer Biol 19: 285-297.
61. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S (2007) Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26: 58-68.
62. Soltés L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J (2006) Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 7: 659-668.
63. Stern R (2003) Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 13: 105R-115R.
64. Stern R (2005) Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol (Paris) 53: 372-382.
65. Stern R (2008) Hyaluronidases in cancer biology. Semin Cancer Biol 18: 275-280.
66. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85: 699-715.
67. Stern R, Kogan G, Jedrzejas MJ, Soltés L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25: 537-557.
68. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278: 32259-32265.
69. Tan J-X, Wang X-Y, Li H-Y, Su X-L, Wang L, Ran L, Zheng K, Ren G-S (2011) HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Int J Cancer 128: 1303-1315.
70. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279: 17079-17084.
71. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111.
72. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165: 1863-1870.
73. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V, Seluanov A (2013) High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499: 346-349.
74. Udabage L, Brownlee GR, Nilsson SK, Brown TJ (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205-217.
75. Voelcker V, Gebhardt C, Averbeck M, Saalbach A, Wolf V, Weih F, Sleeman J, Anderegg U, Simon J (2008) Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 17: 100-107.
76. West DC, Hampson IN, Arnold F, Kumar S (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326.
77. West DC, Kumar S (1989) The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183: 179-196.
78. Wiig H, Aukland K, Tenstad O (2003) Isolation of interstitial fluid from rat mammary tumors by a centrifugation method. Am J Physiol 284: H416-H424.
79. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J, Gao F (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287: 43094-43107.
80. Zhang L, Underhill CB, Chen L (1995) Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428-433.